August 07, 2020

Knowing that product reimbursement affects performance and varies by geography, this article proposes the use of Reimbursement Benchmark Share (RBS) to quantify the influence of reimbursement on a product’s performance.

August 06, 2020

Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.

August 04, 2020

When approached correctly, drug development in the rare disease space can be quite successful – especially when powerhouses across the industry join forces and leverage the power of data to help drive potential treatment options.

August 04, 2020

A look into the traits that hiring managers of pharma companies should be searching for when hiring for a leadership role.

August 04, 2020

How companies are leveraging Real Word Evidence to evaluate therapies under real world conditions in a broader population at a lower cost than using Randomized Clinical Trials.

August 04, 2020

Several months into the COVID-19 pandemic, this article takes a look back at how the launches of new oncology therapies have been impacted.

August 03, 2020

As biopharma companies and research institutes advance the development of promising vaccines against COVID-19, policy makers and health officials have intensified deliberations on strategies for ensuring fair and equitable distribution of anticipated preventives.

August 02, 2020

Andrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.

July 30, 2020

July 30, 2020

IQVIA has announced the launch of OCE Optimizer, which will look to help life sciences companies reach HCPs more effectively.

July 28, 2020

Sponsored Content

The pool of available Real World Data sources for Pharma is both impressive and expanding continuously, but how do you determine the credibility of those sources? Join us as we share tools and strategies to identify the right data source for your organization, and improve both the quality and impact of your Real World Evidence studies. Live: Tuesday, Jul. 28, 2020 at 11am EDT On demand available after airing until Jul. 28, 2021 Register free

July 27, 2020

Titan Pharmaceuticals' Sunil Bhonsle and Indegene's Jamie Peck talk about their new partnership and how it will move forward in the post-COVID environment.

July 27, 2020

Nate Wible and Dan Donovan evaluate the shift from in-person to virtual HCP meetings and look toward the future of this model.

July 24, 2020

Patient advocates, research experts, and industry are calling for more user fee revenues to support CBER programs to advance innovative therapies.

July 23, 2020

Dr. Geeta Vemuri, founder of biopharma investment firm Agent Capital, talks about sustaining a career in the venture capital sector.

July 23, 2020

Pharmaceutical Executive

Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.

July 23, 2020

July 23, 2020

July 22, 2020

Pharmaceutical Executive

Embracing expanded digital models key to future ROI.

July 21, 2020

In adjusting to the long-term side-effects of the coronavirus pandemic, pharma companies will need to focus on change in three areas. Ben van der Schaaf and Aurelien Guichard report.